Back to Search
KAREN TRUITT, DO
DO
Neurology Physician
NPI: 1396867347IndividualAccepts Medicare
Specialties, Licenses & Credentials
Neurology PhysicianPrimary
Psychiatry & Neurology — Neurology
Code: 2084N0400X
49881(MN)
CMS Specialties
PrimaryNEUROLOGY
Education
KANSAS CITY UNIVERSITY OF PHYSICIANS AND SURGEONS
Class of 2005
Research & Publications (12)
Use of an exposure-response model to aid early drug development of an oral sphingosine 1-phosphate receptor modulator.
PMID 18948412·J Clin Pharmacol·2009
3-trial
Model-based development of a PPARgamma agonist, rivoglitazone, to aid dose selection and optimize clinical trial designs.
PMID 18936283·J Clin Pharmacol·2008
3-trial
Colesevelam hydrochloride therapy in patients with type 2 diabetes mellitus treated with metformin: glucose and lipid effects.
PMID 18852398·Arch Intern Med·2008
4-observational
Efficacy and safety of colesevelam in patients with type 2 diabetes mellitus and inadequate glycemic control receiving insulin-based therapy.
PMID 18663165·Arch Intern Med·2008
4-observational
Pain relief model for a COX-2 inhibitor in patients with postoperative dental pain.
PMID 18522627·Br J Clin Pharmacol·2008
4-observational
Colesevelam HCl improves glycemic control and reduces LDL cholesterol in patients with inadequately controlled type 2 diabetes on sulfonylurea-based therapy.
PMID 18458145·Diabetes Care·2008
2-rct
A randomized, double-blind, celecoxib- and placebo-controlled study of the effectiveness of CS-706 in acute postoperative dental pain.
PMID 17577461·Clin Ther·2007
4-observational
Predictive population pharmacokinetic/pharmacodynamic model for a novel COX-2 inhibitor.
PMID 17322148·J Clin Pharmacol·2007
8-other
A randomized, double-blind, one-week study comparing effects of a novel COX-2 inhibitor and naproxen on the gastric mucosa.
PMID 17216336·Dig Dis Sci·2007
4-observational
Development of a predictive pharmacokinetic model for a novel cyclooxygenase-2 inhibitor.
PMID 16638737·J Clin Pharmacol·2006
3-trial
A placebo and active comparator-controlled trial of rofecoxib for the treatment of rheumatoid arthritis.
PMID 12369656·Scand J Rheumatol·2002
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 4212 N 16TH ST
PHOENIX, AZ 85016 - Phone
- (602) 263-1200
Quick Facts
- NPI
- 1396867347
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 21
- Publications
- 12
Are you this provider?
Claim Your Profile